| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
5,075 |
4,554 |
$593K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
3,592 |
3,067 |
$557K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,285 |
1,098 |
$304K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
726 |
645 |
$63K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
822 |
663 |
$58K |
| 92587 |
|
1,099 |
795 |
$40K |
| 59025 |
Fetal non-stress test |
262 |
196 |
$23K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,385 |
2,122 |
$20K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
110 |
93 |
$9K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
252 |
231 |
$7K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
834 |
710 |
$7K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
143 |
124 |
$5K |
| 70450 |
Computed tomography, head or brain; without contrast material |
137 |
115 |
$3K |
| 93976 |
|
90 |
66 |
$1K |
| 87081 |
|
226 |
194 |
$985.67 |
| 81025 |
|
773 |
591 |
$908.29 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
783 |
613 |
$834.17 |
| 71046 |
Radiologic examination, chest; 2 views |
863 |
762 |
$455.02 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
567 |
441 |
$407.59 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
114 |
95 |
$384.49 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
530 |
394 |
$364.94 |
| 84443 |
Thyroid stimulating hormone (TSH) |
66 |
55 |
$256.40 |
| 80053 |
Comprehensive metabolic panel |
858 |
694 |
$237.19 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
413 |
319 |
$231.34 |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
13 |
12 |
$208.89 |
| 71045 |
Radiologic examination, chest; single view |
544 |
439 |
$173.15 |
| 87088 |
|
473 |
386 |
$138.36 |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
39 |
30 |
$71.05 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,757 |
1,364 |
$51.16 |
| 74018 |
|
13 |
13 |
$39.44 |
| 81001 |
|
1,024 |
807 |
$19.96 |
| 36415 |
Collection of venous blood by venipuncture |
912 |
740 |
$13.83 |
| 86140 |
|
30 |
26 |
$12.13 |
| 80076 |
|
233 |
172 |
$11.44 |
| 80305 |
|
180 |
145 |
$8.88 |
| 83690 |
|
401 |
306 |
$4.70 |
| 81003 |
|
115 |
106 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
361 |
263 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
93 |
88 |
$0.00 |
| 82947 |
|
26 |
20 |
$0.00 |
| 82310 |
|
26 |
20 |
$0.00 |
| 82565 |
|
25 |
19 |
$0.00 |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
14 |
12 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
14 |
12 |
$0.00 |
| 84520 |
|
26 |
20 |
$0.00 |
| 87430 |
|
588 |
520 |
$0.00 |
| 87070 |
|
164 |
149 |
$0.00 |
| 84484 |
|
372 |
253 |
$0.00 |
| 83605 |
|
18 |
16 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
126 |
107 |
$0.00 |
| 85379 |
|
14 |
12 |
$0.00 |
| 83735 |
|
34 |
29 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
280 |
235 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
48 |
40 |
$0.00 |
| 80051 |
|
26 |
20 |
$0.00 |